Jonathan Marron

Jonathan Marron, MD, MPH, HEC-C

Director of Clinical Ethics
Assistant Professor of Pediatrics
Member, HMS Center for Bioethics

Jonathan Marron, MD, MPH, HEC-C, is a pediatric oncologist, bioethicist, health services researcher, and educator at Boston Children's Hospital and the Dana-Farber Cancer Institute. He received his MD at the University of California, Los Angeles David Geffen School of Medicine and completed his residency training in Pediatrics at Stanford University, after which he completed fellowships in Clinical Medical Ethics at the University of Chicago's MacLean Center for Clinical Medical Ethics, in Pediatric Hematology/Oncology at BCH/DFCI, and in Pediatric Health Services Research at BCH/HMS. He also received a Master's Degree in Public Health from the Harvard T.H. Chan School of Public Health and served as a Post-doctoral Research Scholar at the HMS Center for Bioethics. In addition to his clinical and research work, Jon teaches ethics courses in the HMS medical school curriculum and the HMS Master's in Bioethics graduate program (“Introduction to Clinical Ethics” and “Pediatric Bioethics”). Dr. Marron's research focuses on the intersection of ethics and decision-making, with a particular interest in pediatric cancer genomic sequencing and other advanced and emerging technologies. His bioethical areas of interest include pediatric ethics, ethical issues in genomics, informed consent, healthcare disparities, and research ethics. Dr. Marron has received funding from such groups as the American Society of Clinical Oncology, the National Institutes of Health (National Cancer Institute and the National Center for Advancing Translational Sciences) and has published in such journals as JAMA Pediatrics, the American Journal of Bioethics, JAMA Oncology, the Journal of Clinical Oncology, and Pediatrics.

Publications View
Ethical considerations in genomic testing for hematologic disorders.
Authors: Authors: Marron JM, Joffe S.
Blood
View full abstract on Pubmed
Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling.
Authors: Authors: Cohen B, Roth M, Marron JM, Gray SW, Geller DS, Hoang B, Gorlick R, Janeway KA, Gill J.
Ann Surg Oncol
View full abstract on Pubmed
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.
Authors: Authors: Marron JM, DuBois SG, Glade Bender J, Kim A, Crompton BD, Meyer SC, Janeway KA, Mack JW.
Pediatr Blood Cancer
View full abstract on Pubmed
Against "Healthy Paternalism" at the End of Life.
Authors: Authors: Marron JM, Truog RD.
JAMA Oncol
View full abstract on Pubmed
Multimodality Treatment of Pediatric Esthesioneuroblastoma.
Authors: Authors: Venkatramani R, Pan H, Furman WL, Marron JM, Haduong J, Friedrich-Medina P, Mahajan A, Bavle A, Wu H, Chintagumpala M.
Pediatr Blood Cancer
View full abstract on Pubmed
When to say when: How aggressively to care for children with multiply relapsed cancer?
Authors: Authors: Marron JM, Mack JW.
Pediatr Blood Cancer
View full abstract on Pubmed
Physician attitudes toward industry: room for improvement.
Authors: Authors: Marron J.
Arch Surg
View full abstract on Pubmed
Ethical issues in innovative colorectal surgery.
Authors: Authors: Marron JM, Siegler M.
Dis Colon Rectum
View full abstract on Pubmed